Amgen Inc. (AMGN) Return on equity 2016–2025
Amgen Inc. (AMGN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
89.1%FY2025 · since FY2016: 25.8% → 89.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 89.1% | +19.5 pp |
| FY2024 | 69.6% | -38.2 pp |
| FY2023 | 107.8% | -71.2 pp |
| FY2022 | 179.0% | +91.0 pp |
| FY2021 | 88.0% | +10.8 pp |
| FY2020 | 77.2% | -3.9 pp |
| FY2019 | 81.1% | +13.9 pp |
| FY2018 | 67.2% | +59.3 pp |
| FY2017 | 7.8% | -18.0 pp |
| FY2016 | 25.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice